Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 71335-2156

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 71335-2156). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cyclobenz Str)

Chemical Structure (Cyclobenz Str)
Chemical structure diagram of Cyclobenzaprine Hydrochloride showing the molecular arrangement with fused aromatic rings and side chains, including the hydrochloride component.*
FDA Label Image

Label (Lbl713352156)

Label (Lbl713352156)
Cyclobenzaprine HCl 5 mg Tablet film coated packaging label by Bryant Ranch Prepack. The label describes the tablet as yellow to orange, pentagon (5-sided) biconvex shape. It advises storage at room temperature (20°-25°C) and includes warnings about potential drowsiness and keeping the medication out of children's reach. The NDC 71335-2156-1 and a comparison to Flexeril 5 mg Tablet by Aurobindo Pharma are visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.